The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Rheumatology

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/41.4.367PMID 11961165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia.

  2010cited by this paper
• A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.

  2000cited by this paper
• Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies

  2000cited by this paper
• Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

  2000cited by this paper
• Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

  2000cited by this paper
• Intravenous immunoglobulin treatment of lupus nephritis.

  2000cited by this paper
• Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.

  1999cited by this paper
• Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.

  1999cited by this paper
• Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.

  1999cited by this paper
• Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin

  1999cited by this paper
• Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy.

  1999cited by this paper
• Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.

  1999cited by this paper
• Intravenous immunoglobulin in combined therapy for children with juvenile rheumatoid arthritis (evaluation of therapeutical efficiency and factors that influence them)

  1998cited by this paper
• [Intravenous immunoglobulin in combined therapy for children with juvenile rheumatoid arthritis (evaluation of therapeutical efficiency and factors that influence them)].

  1998cited by this paper
• Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

  1997cited by this paper
• Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.

  1997cited by this paper
• Mechanisms of action of intravenous immune globulin in immune‐mediated diseases

  1996cited by this paper
• Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.

  1996cited by this paper
• Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.

  1996cited by this paper
• Modulation of complement‐mediated immune damage by intravenous immune globulin

  1996cited by this paper
• Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis.

  1996cited by this paper
• High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.

  1996cited by this paper
• The viral safety of intravenous immune globulin

  1996cited by this paper
• Intravenous immunoglobulin as sole therapy for systemic vasculitis.

  1996cited by this paper
• Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

  1995cited by this paper
• Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.

  1995cited by this paper
• Dramatic responses to intravenous immunoglobulin in vasculitis *

  1995cited by this paper
• Normal fetal growth in women with antiphospholipid syndrome treated with high‐dose intravenous immunoglobulin (IVIG)

  1995cited by this paper
• Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.

  1994cited by this paper
• Requirements for safety and quality of intravenous immunoglobulin G preparations.

  1994cited by this paper
• Long-term i.v. Ig treatment in systemic lupus erythematosus.

  1994cited by this paper
• Pathogenic anti‐DNA idiotype‐reactive IgG in intravenous immunoglobulin preparations

  1994cited by this paper
• Acute renal failure after intravenous immunoglobulin therapy.

  1994cited by this paper
• Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.

  1994cited by this paper
• Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.

  1994cited by this paper
• Side-effects of intravenous immune globulins.

  1994cited by this paper
• Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.

  1994cited by this paper
• Juvenile dermatomyositis: treatment with intravenous gammaglobulin

  1994cited by this paper
• Transmission of viral infections through intravenous immune globulin.

  1994cited by this paper
• Inactivation and Elimination of Viruses during Preparation of Human Intravenous Immunoglobulin

  1994cited by this paper
• Pooled intravenous immunoglobulin in the management of systemic vasculitis.

  1993cited by this paper
• Acute renal failure resulting from intravenous immunoglobulin therapy.

  1993cited by this paper
• Expression and control of the natural autoreactive IgG repertoire in normal human serum

  1993cited by this paper
• Adverse Effects of Intravenous Immunoglobulin

  1993cited by this paper
• Effect of IgM‐enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti‐endotoxin antibodies in bone marrow transplantation

  1993cited by this paper
• A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

  1993cited by this paper
• Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin.

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• High-dose intravenous immune globulin and acute renal failure.

  1992cited by this paper
• Intravenous immunoglobulin therapy: magic or black magic.

  1992cited by this paper
• High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.

  1992cited by this paper
• Treatment of dermatomyositis with intravenous gammaglobulin.

  1991cited by this paper
• Treatment of systemic vasculitis with pooled intravenous immunoglobulin.

  1991cited by this paper
• Lupus refractory pleural effusion: transient response to intravenous immunoglobulins.

  1991cited by this paper
• Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.

  1991cited by this paper
• High-dose immunoglobulin therapy in pericarditis caused by SLE.

  1990cited by this paper
• HUMAN IMMUNOGLOBULIN THERAPY FOR PREECLAMPSIA ASSOCIATED WITH LUPUS ANTICOAGULANT AND ANTICARDIOLIPIN ANTIBODY

  1990cited by this paper
• Intravenous immunoglobulin for polymyositis and dermatomyositis.

  1990cited by this paper
• Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins.

  1990cited by this paper
• High dose immunoglobulin therapy in severe juvenile chronic arthritis: long-term follow-up in 16 patients.

  1990cited by this paper
• Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis.

  1990cited by this paper
• Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

  1989cited by this paper
• Intravenous gamma-globulin, antiphospholipid antibodies, and pregnancy.

  1989cited by this paper
• Trial of IgG therapy for lupus nephritis--report of two cases with a successful response.

  1989cited by this paper
• The comparison of gammaglobulin to steroids in treating adult immune thrombocytopenia

  1989cited by this paper
• Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin.

  1988cited by this paper
• LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULIN

  1988cited by this paper
• Development of selective IgM deficiency in systemic lupus erythematosus patients with disease of long duration.

  1987cited by this paper
• High-dose gammaglobulin therapy for Kawasaki disease.

  1987cited by this paper
• Microvascular deposition of complement membrane attack complex in dermatomyositis.

  1986cited by this paper
• Non-A, non-B hepatitis after intravenous gammaglobulin.

  1986cited by this paper
• High-dose intravenous gammaglobulin for membranous nephropathy.

  1986cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• The treatment of Kawasaki syndrome with intravenous gamma globulin.

  1986cited by this paper
• Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

  1985cited by this paper
• Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood.

  1985cited by this paper
• High-dose intravenous gammaglobulin for Kawasaki disease.

  1983cited by this paper
• High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

  1981cited by this paper
• Book reviewImmunoglobulins: Biological Aspects and Clinical Uses: EZIO MERLER, (ed.): National Academy of Sciences, Washington, D.C., 1971, 404 pp., $9.50.

  1971cited by this paper
• Intravenous Administration of Human γ‐Globulin *

  1962cited by this paper
• Intravenous administration of human gamma-globulin.

  1962cited by this paper
• Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren

  1890cited by this paper

• Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus

  2025cites this paper
• Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity

  2025cites this paper
• Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling

  2025cites this paper
• Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine

  2023cites this paper
• Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male.

  2021cites this paper
• Evaluation of Intravenous Immunoglobulin G treatment in Outpatients Rheumatology Practice

  2021cites this paper
• Using the K/BxN mouse model of endogenous, chronic, rheumatoid arthritis for the evaluation of potential immunoglobulin-based therapeutic agents, including IVIg and Fc-μTP-L309C, a recombinant IgG1 Fc hexamer

  2019cites this paper
• The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms.

  2019cites this paper
• Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris

  2018cites this paper
• GM‐CSF and IL‐4 are not involved in IVIG‐mediated amelioration of ITP in mice: a role for IL‐11 cannot be ruled out

  2018cites this paper
• Treatment of ANCA-associated systemic vasculitis

  2017cites this paper
• Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases.

  2017cites this paper
• Intravenous Immunoglobulin and Its Clinical Applications.

  2017cites this paper
• Nociceptive neuronal Fc-gamma receptor I is involved in IgG immune complex induced pain in the rat.

  2017cites this paper
• Intravenous Immunoglobulin and Its Clinical Applications

  2017cites this paper
• Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy

  2017cites this paper
• Production d'IgG sialylées en CHO et impact sur leurs fonctions effectrices

  2016cites this paper
• Managing patients with side effects and adverse events to immunoglobulin therapy

  2016cites this paper
• Inmuno glo bulinas e ndo ve no s as e n las e nfe rme dade s auto inmune s s is té micas

  2016cites this paper
• Prevention of Stroke in Rheumatoid Arthritis

  2015cites this paper
• The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis.

  2015cites this paper
• Genetics and novel aspects of therapies in systemic lupus erythematosus.

  2015cites this paper
• Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection.

  2015cites this paper
• Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

  2014cites this paper
• Evaluating the potential of continuous processes for monoclonal antibodies : economic, environmental and operational feasibility

  2014cites this paper
• Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.

  2014cites this paper
• Gammaglobulina intravenosa en el tratamiento de la artritis idiopática juvenil

  2013cites this paper
• The anti-inflammatory properties of intravenous immunoglobulin in a murine model of allergic airway disease ; effects on the development of regulatory T-cells

  2013cites this paper
• When conventional treatment fails: the role of intravenous immunoglobulin in recurrent pregnancy loss secondary to antiphospholipid syndrome

  2013cites this paper
• Correction of fertility disorders in patients with cryoglobulinemia

  2013cites this paper
• INTERLEUKIN-11 IS A KEY MEDIATOR OF INTRAVENOUS IMMUNOGLOBULIN EFFECTS IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS

  2013cites this paper
• Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

  2012cites this paper
• Diagnosis and treatment of pemphigus.

  2012cites this paper
• Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren’s syndrome

  2012cites this paper
• The role of high-dose intravenous immunoglobulin in rheumatology.

  2010cites this paper
• A dramatic response to intravenous immunoglobulin in a patient with mixed cryoglobulinemia.

  2010cites this paper
• NK Cells, Autoantibodies, and Immunologic Infertility: A Complex Interplay

  2010cites this paper
• [Treatment of ANCA-associated systemic vasculitis].

  2010cites this paper
• Treatment of ANCA-associated systemic vasculitis

  2010cites this paper
• Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not!

  2009cites this paper
• 5. High Dose Intravenous Immunoglobulin

  2009cites this paper
• Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.

  2009cites this paper
• Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.

  2008cites this paper
• A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis.

  2008cites this paper
• Le immunoglobuline nella terapia delle malattie reumatiche Intravenous immunoglobulin for rheumatic diseases

  2007cites this paper
• High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus

  2007cites this paper
• Intravenous Immunoglobulin Therapy in Systemic Lupus Erythematosus

  2007cites this paper
• The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases

  2007cites this paper
• The importance of regional lymph nodes for mucosal tolerance

  2006cites this paper
• Intravenous immunoglobulin for juvenile idiopathic arthritis

  2006cites this paper
• Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.

  2005cites this paper
• The Autoreactivity of Therapeutic Intravenous Immunoglobulin (IVIg) Preparations Depends on the Fractionation Methods Used

  2005cites this paper
• Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

  2005cites this paper
• Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases

  2005influential citation
• Serum IgM, IgG and IgA block by F(ab′)2‐dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self‐antigens

  2005cites this paper
• Immunoglobulin therapy: history, indications, and routes of administration

  2004cites this paper
• Preferential expression of IgG2b in nose draining cervical lymph nodes and its putative role in mucosal tolerance induction

  2004cites this paper
• The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease.

  2004cites this paper
• Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.

  2003cites this paper
• Inmunoglobulinas endovenosas en las enfermedades autoinmunes sistémicas

  2003cites this paper
• Clinical utility of intravenous immunoglobulins in autoimmune diseases

  2003cites this paper
• [Intravenous immunoglobulins in the systemic autoinmune diseases].

  2003cites this paper
• Immunomics: Entwicklung einer ESI-MS basierten Methodik zur Differenzierung und Quantifizierung von humanen Immunglobulinen und ihrer Glykosylierung

  2003cites this paper
• Intravenous immune globulins: an update for clinicians

  2003cites this paper